TGFB1 and hepatocellular carcinoma: In minimal residual disease (MRD) of HCC, programmed cell death 1 ligand 1 (PD-L1)-positive M2 macrophages interact with cancer stem cells through the TGF-β signaling pathway, sustaining tumor cell persistence.